Literature DB >> 1081003

A rapid method for purification of human granulocyte cationic neutral proteases: purification and characterization of human granulocyte chymotrypsin-like enzyme.

G Feinstein, A Janoff.   

Abstract

A chymotrypsin-like enzyme (EC 3.4.21.-) was purified from granules of human neutrophiles (polymorphonuclear leucocytes). The isolation procedure included differential salt extractions of the granules followed by affinity chromatography on 4-phenylbutylamine-Affi-Gel. This rapid purification method resulted in obtaining pure enzyme in relatively high yield in short time. The purified granulocyte chymotrypsin-like enzyme has a minimum Mr of 22 378, calculated from its amino acid composition. The Mr value obtained by sodium dodecyl sulphate gel electrophoresis was 20 000-23 000. The enzyme did not react with antibodies which are monospecific to granulocyte elastase. The granulocyte chymotrypsin-like enzyme was inactivated by Dip-F and by the chloromethyl ketone derivatives Z-PheCH2Cl and Z-(Gly)2-PheCH2Cl but not by Tos-PheCH2Cl. It therefore appears that the enzyme has serine and histidine side chains in its active site, like pancreatic chymotrypsin. The granulocyte enzyme substrate specificity is similar to that of pac-Tyr-Nan and Ac-Phe-1-ONap. It also has an intrinsic weak hydrolytic activity towards some classical elastase substrates such as Boc-Ala-ONp and Ac-DL-Ala-1-ONap. The granulocyte enzyme is inhibited by human serum and by human alpha1-antitrypsin. Its affinity for alpha1-antitrypsin is weaker than that of granulocyte elastase for the same inhibitor. The enzyme is stable at neutral pH at 37 degrees C, but unstable at pH 3.5 and at elevated temperature.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081003     DOI: 10.1016/0005-2744(75)90076-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Serine proteinase from Staphylococcus aureus enhances elastin degradation by elastases in the presence of human alpha-1-proteinase inhibitor.

Authors:  D Nowak; J Miedzobrodzki
Journal:  Antonie Van Leeuwenhoek       Date:  1991-02       Impact factor: 2.271

2.  Human cathepsin G. Catalytic and immunological properties.

Authors:  P M Starkey; A J Barrett
Journal:  Biochem J       Date:  1976-05-01       Impact factor: 3.857

3.  Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts.

Authors:  J O'Donnell-Tormey; J P Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Glycosidases and proteases of alveolar macrophages obtained by bronchoalveolar lavage from smokers and non-smokers.

Authors:  A Scharfman; J J Lafitte; A B Tonnel; C Aerts; B Sablonniere; P Roussel
Journal:  Lung       Date:  1980       Impact factor: 2.584

5.  Inhibition of human neutrophil elastase activity by encapsulated serum (Serumsome) therapy.

Authors:  S H Kuhn; M C Finkelstein
Journal:  Appl Biochem Biotechnol       Date:  1984       Impact factor: 2.926

6.  Purification and characterization of a human neutrophil neutral protease. The neutral peptide-generating protease.

Authors:  J S Coblyn; K F Austen; B U Wintroub
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Hydrolysis of the elastase substrate succinyltrialanine nitroanilide by a metal-dependent enzyme in rheumatoid synovial fluid.

Authors:  J Saklatvala
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. I. Penetration of enzyme into rabbit articular cartilage and release of 35SO4-labeled material from the tissue.

Authors:  A Janoff; G Feinstein; C J Malemud; J M Elias
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

9.  The role of lysosomal elastase in the digestion of Escherichia coli proteins by human polymorphonuclear leukocytes: experiments with living leukocytes.

Authors:  J Blondin; A Janoff
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  Modulation of human mononuclear cell responses by neutrophil-derived factors. II. Partial characterization of a neutrophil-derived lymphocyte-enhancing factor (N-LEF).

Authors:  R S Panush
Journal:  Inflammation       Date:  1983-03       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.